title: Reply: Duration of Triple Therapy: A Clinical Question Yet to Be Answered.
authors.forename: Nikolaus
authors.initials: N
authors.lastname: Sarafoff
authors.forename: Robert A
authors.initials: RA
authors.lastname: Byrne
authors.forename: Julinda
authors.initials: J
authors.lastname: Mehilli
authors.forename: Dirk
authors.initials: D
authors.lastname: Sibbing
authors.forename: Steen D
authors.initials: SD
authors.lastname: Kristensen
authors.forename: Karl-Ludwig
authors.initials: KL
authors.lastname: Laugwitz
authors.forename: Michael
authors.initials: M
authors.lastname: Maeng
authors.forename: Adnan
authors.initials: A
authors.lastname: Kastrati
mesh_terms: D001241:Aspirin / Q000008:administration & dosage*; D054855:Drug-Eluting Stents; D005260:Female; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D013988:Ticlopidine / Q000031:analogs & derivatives*
chemical_list: D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine; D001241:Aspirin